Development of a new method to deliver CRISPR

Amsterdam UMC researchers Rubina Baglio and Michiel Pegtel together with Daniël Warmerdam from the CRISPR Platform have received a grant from the Cancer Center Amsterdam to further develop a new delivery method for CRISPR/Cas in cells and tissues for the potential application in the treatment of cancer.